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1. Introduction 
Asparate aminotransferase (EC 2.6.1 .l) has been 
extensively studied as a representative of the pyridoxal 
5’-phosphate (pyridoxal-P&dependent enzymes. The 
enzyme catalyzes the reversible transfer of the amino 
group between L-aspartic acid and cY-ketoglutaric acid, 
and plays an important role in nitrogen metabolism. 
Animal and plant tissues contain both mitochondrial 
and cytosolic isoenzymes [l] . The primary structures 
of both isoenzymes from pig heart muscle have been 
elucidated [2,3] . Preliminary crystallographic data 
have been reported for the large and single crystals of 
cytosolic [4,5] and mitochondrial isoenzymes [6]. 
Mammalian aspartate aminotransferases are immuno- 
chemically distinct from the bacterial enzymes [7] . 
Structural studies of the bacterial enzymes have not 
been done. The enzyme has been purified to homo- 
geneity from Pseudomonas striata and crystallized 
[8] . However, its low content in cells and low yield 
in purification prompted a search for other bacterial 
sources to produce it more abundantly. The aspartate 
aminotransferases have been highly purified from 
Escherichia coli K-12 [9], its mutant [lo] and 
Crooks strain [ 1 l] , but none of them have been 
obtained in a crystalline form. 
We describe here high yield purification, crystalliza- 
tion and some properties of aspartate aminotransferase 
from Escherichia cob B as a first approach to the 
comparative studies on the enzyme. 
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2. Materials and methods 
Escherichia coli B was grown in a medium com- 
posed of 0.5% succinate, 0.5% L-aspartate, 0.2% 
K2HP04, 0.2% KH,P04, 0.2% NaCl and 0.01% 
MgS04 - 7 H,O. The pH was adjusted to 7.5 with 
NaOH. After cultivation at 28’C for -18 h under 
aeration, the cells were harvested and washed with a 
0.85% NaCl solution. Malate dehydrogenase was pur- 
chased from Boehringer-Mannheim; polyethylene 
glycol (av. mol. wt 4000) and NADH from Sigma; 
and amino acids from Kyowa Hakko Kogyo, Tokyo. 
The enzyme was assayed by a modification of the 
coupled malate dehydrogenase method [ 121 as 
follows: The reaction mixture contained 100 pmol 
Tris-HCI buffer (pH 8.5) 50 pmol L-aspartate, 
5 pmol a-ketoglutarate, 100 nmol NADH, 15 nmol 
pyridoxal-P and 25 pgmalate dehydrogenase in 1 .O ml 
final vol. The decrease in A,, was measured at 25°C 
with a Union Giken SM-401 recording spectro- 
photometer. For the determination of amino donor 
specificity, the reaction system consisted of 200 pmol 
Tris-HCl buffer (pH 8.5) 300 pmol amino acids 
except L-tyrosine (30pmol), L-tryptophan (200 pmol) 
and L-aspartate (100 pmol), 10 pmol c+ketoglutarate 
and 30 nmol pyridoxal-P in 2.0 ml final vol. L-Gluta- 
mate produced was determined with a JEOL JLCdAH 
automatic amino acid analyzer. 
One unit of enzyme was defined as the amount of 
enzyme that catalyzes the formation of 1 .O pmol 
L-glutamate or NAD/min. The specific activity was 
expressed as units/mg protein. Protein was determined 
by the Lowry method [ 131 using serum albumin as a 
standard. 
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3. Results and discussion 
3.1. firijication and crystallization 
The washed cells were suspended in 0.02 M potas- 
sium phosphate buffer (PH 7.0) containing 2 X lo-’ M 
pyridoxal-P and 0.01% 2mercaptoethanol and sub- 
jected to sonication followed by centrifugation. The 
cell-free extracts were fractionated with ammonium 
sulfate (30-75% saturation). The resulting precipitate 
was dissolved in 0.01 M potassium phosphate buffer 
(pH 7.0) cont~ning 1 O-’ M pyridox~-P and dialyzed 
against the same buffer. The dialyzed enzyme was 
applied to a DEAE-cellulose column equilibrated with 
the dialysis buffer. The enzyme fraction eluted with 
the buffer supplemented with 0.15 M NaCl was heated 
at 58-63°C for 5 min and the resulting precipitate 
discarded. The supernat~t was concentrated by addi- 
tion of ammonium sulfate (75% saturation). The 
precipitate was dissolved in a minimum volume of 
distilled water and applied to a Sephacryl S-200 
column buffered with 0.01 M potassium phosphate 
buffer (pH 7.0) containing lo-’ M pyridoxal-P. The 
active fractions were concentrated and dialyzed against 
0.02 M sodium acetate buffer (pH 4.8) containing 
IO-’ M pyridoxal-P. After centrifugation the enzyme 
was applied to a DEAE-cellulose column equilibrated 
with the dialysis buffer. The elution was carried out 
with a linear gradient (O-O.3 M NaCi) and the enzyme 
was eluted with the buffer containing -0.15 M NaCI. 
The active fractions were collected and applied to a 
hydroxyapatite column equilibrated with 0.001 M 
potassium phosphate buffer (pH 6.0). The enzyme 
was eluted with -0.01 M potassium phosphate buffer, 
when the elution was performed with a linear gradient 
(0.001-0.1 M). Thus, the enzyme was purified about 
200-fold. A summary of the purification is presented 
in table 1. 
The enzyme preparation with spec. act. 200 was 
crystallized from a polyethylene glycol solution by 
the vapour diffusion technique [ 141. Protein solution, 
20 ~1 (10 mg/ml 0.0 1 M potassium phosphate buffer 
(pH 7.0)) was placed in a well of a hollow slide glass. 
To the droplet were added 10 ~1 10m2 M pyridoxal-P 
and 10 ~1 of a 9% (w/v) polyethylene glycof solution. 
The slide glass was placed on a small plastic sandwich 
box which was enclosed in a large sandwich box, and 
the box was sealed and maintained at 4°C for -7-10 
days. The large crystals measuring up to about 
1.5 X 0.4 X 0.2 mm3 were formed as shown in fig.1. 
1 
Fig. 1. Crystals of aspartate aminotransferase fcomE.wherichia 
coli B . 
Table 1 
Purification of aspartate aminotransferase from E’scherichia coli B 
Fraction 
Crude extract 
DEAE-cefiulose 
chromatography (pH 7.0) 
Heat treatment 
Sephacryl S-200 
chromatography 
DEAE-cellulose 
chromatography (pH 4.8) 
Hydroxyapatite 
chromatography 
.__~ 
Total 
protein (mg) 
- 
26 000 
4700 
1500 
590 
Total 
unit 
23 000 
17 300 
17 000 
12 420 
137 9200 67.15 40 
23 4600 200.00 20 
Spec. Yield 
act. (%I 
0.88 100 
3.68 75 
11.33 74 
21.05 54 
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Fig.2. Disc gel electrophetic patterns of the enzyme. The 
samples were electrophoresed under the conditions in [ 181 
gel (I), and in [ 191 gel (II). In the estimation of the subunit 
molecular weight were used bovine serum albumin (M, 68 000), 
catalase (6000), ovalbumin (43 000), aldolase (40 000) and 
or-chymotrypsinogen (25 000) as standards. 
Many attempts were made to crystallize the enzyme 
with ammonium sulfate without success. 
3.2. Properties 
The purified enzyme was shown to be homogeneous 
by the criteria of ultracentrifugation and disc-gel 
electrophoresis (fig.2(1)). The molecular weight was 
estimated to be 80 000 by the gel filtration with 
Sephadex G-l 50 [ 151 and 84 000 by the meniscus 
depletion sedimentation equilibrium method [ 161 
assuming a partial specific volume of 0.74. SDS poly- 
acrylamide disc gel electrophoresis (fig.2(11)) gave a 
single band with mol. wt 43 000 + 1000 suggesting 
that the nzyme was composed of two subunits 
identical in molecular weight. The enzyme showed 
absorption maxima at 280 nm (E 74 800) and 360 nm 
(E 13 500) at pH 8.5, and 280 nm and 440 nm 
(E 12 900) at pH 5.5. The enzyme had a maximum 
activity in the pH range of 7.5-8.5. The Km values 
determined by spectrophotometric determination of 
oxalacetate by the method in [ 171 were 0.01 mM for 
oxalacetate, 15 mM for L-glutamate, 0.24 mM for 
cr-ketoglutarate and 1.3 mM for L-aspartate. The same 
values for L-aspartate and a-ketoglutarate were 
obtained by the assay method with malate dehydro- 
genase. These properties are similar to those reported 
for the mammalian isoenzymes [l] . 
The enzyme from E. cob B catalyzed the trans- 
amination of aromatic amino acids as well as Lgluta- 
mate and L-aspartate with cr-ketoglutarate. The relative 
activity was 100 for L-glutamate, 30 for Laspartate, 
11 for L-tryptophan, 6.2 for L-phenylalanine, 1.5 for 
L-tyrosine and 1 .O for L-methionine. Similar high 
reactivity toward aromatic amino acids has been 
reported with other bacterial aspartate aminotrans- 
ferases [8-l l] . The mammalian enzymes show higher 
substrate specificity [l] . 
Table 2 
Amino acid composition of aspartate aminotransferase from 
Escherichia coli B 
Amino acid Residuesa/subunit 
Tryptophanb 4.4 
Ly sine 16.7 
Histidine 5.7 
Arginine 21.8 
Aspartate 42.4 
Threonine 22.3 
Serine 18.1 
Glutamate 47.6 
Proline 14.6 
Glycine 29.6 
Alanine 45.5 
Valine 25.4 
Methionine 7.9 
Isoleucine 17.3 
Leucine 35.9 
Tyrosine 11.3 
Phenylalanine 19.9 
CysteineC 6.3 
a The average or extrapolated (threonine and serine) values 
from 24,48 and 72 h hydrolysis in 5.7 N HCl [ 201. The 
molecular weight of The subunit was assumed to be mol. wt 
42 000 
b Value determined spectrophotometrically [21] 
’ Determined as cysteic acid [22] 
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The amino acid composition of the enzyme is 
shown in table 2. The enzyme is similar to E. coli 
Crooks enzyme [ 1 l] in the amino acid composition, 
although tryptophan residue was not determined in 
the latter enzyme. On the other hand, the amino acid 
composition resembles none of those reported with 
pig heart isoenzymes. 
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